1. Neurologic Diseases and Neurogenetics Group, Bellvitge Institute for Biomedical Research (IDIBELL), 08907 L’Hospitalet de Llobregat, Barcelona, Spain
2. CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, 08907 L’Hospitalet de Llobregat, Barcelona, Spain
3. Neuropharmacology & Pain Group, Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, 08907 L’Hospitalet de Llobregat, Barcelona, Spain
4. Neuropathology Group, Bellvitge Institute for Biomedical Research (IDIBELL), 08907 L’Hospitalet de Llobregat, Barcelona, Spain
5. Clinical Neuroproteomics Unit, Proteomics Platform, Proteored-ISCIII, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), diSNA, 31008 Pamplona, Navarra, Spain
6. Molecular and Cellular Neurobiotechnology Group, Institute of Bioengineering of Catalonia (IBEC), Barcelona Institute for Science and Technology, Science Park Barcelona (PCB), 08028 Barcelona, Barcelona, Spain
7. Department of Pathology and Experimental Therapeutics, University of Barcelona, 08907 L’Hospitalet de Llobregat, Barcelona, Spain
8. Emeritus Researcher, Bellvitge Biomedical Research Institute (IDIBELL), Emeritus Professor, University of Barcelona, 08907 L’Hospitalet de Llobregat, Barcelona, Spain